封面
市場調查報告書
商品編碼
2075923

伴侶動物關節炎市場:依動物種類、適應症、治療方法、通路及地區分類

Companion Animal Arthritis Market, By Animal Type, By Indication, By Treatment, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2026 年,伴侶動物關節炎市場規模將達到 50.3 億美元,到 2033 年將達到 85.2 億美元。預計從 2026 年到 2033 年,該市場將以 7.8% 的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 50.3億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 7.80% 2033年市場規模預測: 85.2億美元

骨關節炎(OA)是犬貓常見的疾病。其特徵是進行進行性退化性關節疾病,伴隨輕度發炎。 OA由關節軟骨的退化和異常修復引起,並伴隨軟骨下骨的代謝變化、骨贅形成和滑膜發炎。在伴侶動物中,OA幾乎總是繼發於關節鬆弛、骨軟骨病和創傷等潛在疾病。它是一個涉及關節囊纖維化和骨膜反應的病理過程,導致步態和活動範圍的改變。因此,肌肉骨骼系統和次級關節穩定機制受損,關節軟骨因異常應力和磨損而進一步劣化。

市場動態:

全球伴侶動物關節炎治療市場的主要動力是新療法的研發。例如,加拿大衛生研究院 (CIHR) 於 2021 年資助了一項價值 60 萬美元的電腦輔助設計 (CAD) 計畫。此計畫旨在評估間質幹細胞治療犬骨關節炎的有效性。該研究正在對飼主肘關節或膝關節骨關節炎的犬隻進行隨機、雙盲、安慰劑對照臨床試驗(資料來源:CIHR 計畫資助)。這些研究的成果有望為新型再生醫學方案的潛力提供寶貴的見解。此外,先進治療方案的增加可能會促使更多寵物飼主在獸醫的幫助下積極管理寵物的關節炎。因此,伴侶動物關節炎市場預計將在可預見的未來持續成長。

本研究的主要特點:

  • 本研究揭示了各個細分市場的潛在商機,並說明了該市場極具吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 本研究根據以下參數分析了全球伴侶動物關節炎市場的主要參與者:公司概況、產品系列、主要亮點、財務表現和策略。
  • 本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
  • 這份「全球伴侶動物關節炎治療市場」報告旨在為行業內的各類相關人員提供參考,包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過利用全球伴侶動物關節炎市場分析中使用的各種策略矩陣來簡化決策過程。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 人們對自我形象和自信心的擔憂日益加劇
    • 治療的副作用
    • 尚未開發的新興市場
  • 影響分析
  • 主要亮點
  • 監管趨勢
  • 服務提供組合
  • PEST分析
  • 波特的分析
  • 併購情景
  • 管道分析

第4章:全球伴侶動物關節炎市場:依動物類型分類,2021-2033年

  • 狗
  • 貓
  • 其他

第5章 全球伴侶動物關節炎市場:依適應症分類,2021-2033年

  • 骨關節炎
  • 其他關節炎

第6章 全球伴侶動物關節炎市場:依治療方法分類,2021-2033年

  • 藥物
  • 補充
  • 其他治療方法

第7章 全球伴侶動物關節炎市場:依通路分類,2021-2033年

  • 獸醫醫院和診所
  • 零售藥房
  • 網路商店
  • 其他

第8章 全球伴侶動物關節炎市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 北非
    • 中非
    • 南非

第9章 競爭情勢

  • Vetoquinol
  • NexGen Pharmaceuticals
  • Norbrook
  • Eltech K-Laser srl
  • Zoetis
  • Virbac
  • Elanco
  • Boehringer Ingelheim International GmbH
  • Ceva
  • Dechra Pharmaceuticals PLC
  • Others Prominent Players

第10章

  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI6525

Companion Animal Arthritis Market is estimated to be valued at USD 5.03 Bn in 2026 and is expected to reach USD 8.52 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.8% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 5.03 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 7.80% 2033 Value Projection: USD 8.52 Bn

Osteoarthritis (OA) is a common condition that affects dogs and cats. It is characterized as a low-grade inflammatory, progressive degenerative joint disease. OA results from degeneration and aberrant repair of articular cartilage in association with alterations in subchondral bone metabolism, osteophytosis, and synovial inflammation. In companion animals, OA is almost always secondary to an underlying abnormality, such as joint laxity, osteochondrosis, trauma, etc. It is a pathological process that includes joint capsule fibrosis and periosteal reactions, leading to an altered gait and range of motion. In turn, there is a deterioration of the musculoskeletal system and secondary joint stabilizers, resulting in further deterioration of articular cartilage due to abnormal loading and wear.

Market Dynamics:

The global companion animal arthritis market is mainly driven by the increasing development of novel therapeutics. For instance, the Canadian Institutes of Health Research (CIHR) funded a US$600,000 Computer-aided design (CAD) project launched in 2021 focused on evaluating the efficacy of mesenchymal stem cells for the treatment of osteoarthritis in dogs. The study involves a randomized, double-blinded, placebo-controlled clinical trial involving client-owned dogs with elbow or stifle osteoarthritis (source: CIHR project funding). Findings from these studies will provide valuable insights into the potential of new regenerative medicine options. Furthermore, the greater availability of advanced treatment choices will encourage more pet owners to actively manage their pet's arthritis with the help of veterinarians. This, in turn, will fuel ongoing expansion in the companion animal arthritis market beyond the foreseeable future.

Key features of the study:

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global companion animal arthritis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Vetoquinol, NexGen Pharmaceuticals, Norbrook, Eltech K-Laser s.r.l, Zoetis, Virbac, Elanco, Boehringer Ingelheim International GmbH, Ceva, Dechra Pharmaceuticals PLC .
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global companion animal arthritis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global companion animal arthritis market

Global Companion animal arthritis Market Detailed Segmentation:

  • By Animal Type (Revenue, USD Bn, 2021 - 2033)
  • Dogs
  • Cats
  • Others
  • By Indication (Revenue, USD Bn, 2021 - 2033)
  • Osteoarthritis
  • Other Arthritis
  • By Treatment (Revenue, USD Bn, 2021 - 2033)
  • Medication
    • NSAIDs
    • Monoclonal Antibodies
    • Others Medications
  • Supplements
  • Other Treatment
  • By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
  • Veterinary Hospitals & Clinics
  • Retail Pharmacies
  • Online Stores
  • Others
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Global Companion animal arthritis Market, Key Players
  • Vetoquinol
  • NexGen Pharmaceuticals
  • Norbrook
  • Eltech K-Laser s.r.l
  • Zoetis
  • Virbac
  • Elanco
  • Boehringer Ingelheim International GmbH
  • Ceva
  • Dechra Pharmaceuticals PLC
  • Others Prominent Players .

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Companion Animal Arthritis Market, By Animal Type
    • Global Companion Animal Arthritis Market, By Treatment
    • Global Companion Animal Arthritis Market, By Indication
    • Global Companion Animal Arthritis Market, By Distribution Channel
    • Global Companion Animal Arthritis Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Rising Concerns About Self-Image and Confidence
    • Side effects of treatment options
    • Untapped emerging markets
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Service offering Portfolio
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Pipeline Analysis

4. Global Companion Animal Arthritis Market, By Animal Type, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Dogs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Cats
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

5. Global Companion Animal Arthritis Market, By Indication, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Osteoarthritis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Other Arthritis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

6. Global Companion Animal Arthritis Market, By Treatment, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Medication
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
      • NSAIDs
      • Monoclonal Antibodies
      • Others Medications
  • Supplements
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Other Treatments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

7. Global Companion Animal Arthritis Market, By Distribution Channel, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Veterinary Hospitals & Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Online Stores
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

8. Global Companion Animal Arthritis Market, By Region, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country 2022 -2033
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Vetoquinol
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • NexGen Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Norbrook
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Eltech K-Laser s.r.l
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Zoetis
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Virbac
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Elanco
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Boehringer Ingelheim International GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Ceva
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Dechra Pharmaceuticals PLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Others Prominent Players
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us